BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 6241952)

  • 1. Detection of terminal complement components in experimental immune glomerular injury.
    Adler S; Baker PJ; Pritzl P; Couser WG
    Kidney Int; 1984 Dec; 26(6):830-7. PubMed ID: 6241952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane attack complex deposition in experimental glomerular injury.
    Perkinson DT; Baker PJ; Couser WG; Johnson RJ; Adler S
    Am J Pathol; 1985 Jul; 120(1):121-8. PubMed ID: 3160245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit.
    Groggel GC; Adler S; Rennke HG; Couser WG; Salant DJ
    J Clin Invest; 1983 Dec; 72(6):1948-57. PubMed ID: 6227634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3 dependent, C5 independent immune complex glomerulopathy in the mouse.
    Sawtell NM; Hartman AL; Weiss MA; Pesce AJ; Michael JG
    Lab Invest; 1988 Mar; 58(3):287-93. PubMed ID: 2964544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
    Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
    Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence of events in the glomerular capillary wall at the onset of proteinuria in passive Heymann nephritis.
    Fujigaki Y; Batsford S; Yamashita F; Yonemura K; Hishida A; Kawachi H; Shimizu F; Vogt A
    Virchows Arch; 2001 Feb; 438(2):136-45. PubMed ID: 11253115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and leukocyte independent proteinuria and eicosanoid synthesis in rat membranous nephropathy.
    Rahman MA; Liu CN; Dunn MJ; Emancipator SN
    Lab Invest; 1988 Oct; 59(4):477-83. PubMed ID: 3050273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats.
    Spicer ST; Tran GT; Killingsworth MC; Carter N; Power DA; Paizis K; Boyd R; Hodgkinson SJ; Hall BM
    J Immunol; 2007 Jul; 179(1):172-8. PubMed ID: 17579035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.
    Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG
    Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of antigen distribution on the mediation of immunological glomerular injury.
    Salant DJ; Adler S; Darby C; Capparell NJ; Groggel GC; Feintzeig ID; Rennke HG; Dittmer JE
    Kidney Int; 1985 Jun; 27(6):938-50. PubMed ID: 3894765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of terminal complement complex in active Heymann nephritis.
    de Heer E; Daha MR; Bhakdi S; Bazin H; van Es LA
    Kidney Int; 1985 Feb; 27(2):388-93. PubMed ID: 3886996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats.
    Baker PJ; Ochi RF; Schulze M; Johnson RJ; Campbell C; Couser WG
    Am J Pathol; 1989 Jul; 135(1):185-94. PubMed ID: 2672823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritis.
    Pruchno CJ; Burns MW; Schulze M; Johnson RJ; Baker PJ; Couser WG
    Kidney Int; 1989 Jul; 36(1):65-71. PubMed ID: 2681928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular complement components in human glomerulonephritis.
    Verroust PJ; Wilson CB; Cooper NR; Edgington TS; Dixon FJ
    J Clin Invest; 1974 Jan; 53(1):77-84. PubMed ID: 4586873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new role for complement in experimental membranous nephropathy in rats.
    Salant DJ; Belok S; Madaio MP; Couser WG
    J Clin Invest; 1980 Dec; 66(6):1339-50. PubMed ID: 7440718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury.
    Boyce NW; Holdsworth SR
    J Immunol; 1985 Dec; 135(6):3918-21. PubMed ID: 4067309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the role of complement depletion in experimental membranous nephropathy in the rat.
    Gabbai FB; Mundy CA; Wilson CB; Blantz RC
    Lab Invest; 1988 May; 58(5):539-48. PubMed ID: 3367636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephritogenic potential of sheep antibodies against glomerular basement membrane laminin in the rat.
    Feintzeig ID; Abrahamson DR; Cybulsky AV; Dittmer JE; Salant DJ
    Lab Invest; 1986 May; 54(5):531-42. PubMed ID: 3517487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alterations in glomerular charge on deposition of cationic and anionic antibodies to fixed glomerular antigens in the rat.
    Adler S; Baker P; Pritzl P; Couser WG
    J Lab Clin Med; 1985 Jul; 106(1):1-11. PubMed ID: 3891891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.